d-tagatose has been researched along with glucagon-like peptide 1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astrup, A; Bibby, BM; Buemann, B; Holst, JJ; Rehfeld, JF; Toubro, S | 1 |
Bellon, M; Bound, MJ; Checklin, HL; Horowitz, M; Jones, KL; Little, TJ; Rayner, CK; Wu, T; Young, RL; Zhao, BR | 1 |
1 trial(s) available for d-tagatose and glucagon-like peptide 1
Article | Year |
---|---|
Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans.
Topics: Adult; Blood Glucose; Dietary Sucrose; Disaccharides; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glucose; Hexoses; Humans; Incretins; Insulin; Male; Postprandial Period; Signal Transduction; Sodium-Glucose Transporter 1; Sucrose; Sugar Alcohols; Sweetening Agents; Young Adult | 2012 |
1 other study(ies) available for d-tagatose and glucagon-like peptide 1
Article | Year |
---|---|
D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration.
Topics: Administration, Oral; Adult; Appetite; Blood Glucose; Calorimetry, Indirect; Cholecystokinin; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Epinephrine; Food-Drug Interactions; Fructose; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Hexoses; Humans; Male; Norepinephrine; Peptide Fragments; Protein Precursors; Stereoisomerism; Sweetening Agents; Uric Acid | 2000 |